Deepak Fertilisers & Petrochemicals Corp Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 29, 2025, 5:00 am

Competitors of Deepak Fertilisers & Petrochemicals Corp Ltd

All Competitor Stocks of Deepak Fertilisers & Petrochemicals Corp Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:15 pm

Below is a detailed analysis of the quarterly data for Deepak Fertilisers & Petrochemicals Corp Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,659.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,667.00 Cr. (Mar 2025) to 2,659.00 Cr., marking a decrease of 8.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,146.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,187.00 Cr. (Mar 2025) to 2,146.00 Cr., marking a decrease of 41.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 513.00 Cr.. The value appears strong and on an upward trend. It has increased from 480.00 Cr. (Mar 2025) to 513.00 Cr., marking an increase of 33.00 Cr..
• For OPM %, as of Jun 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Mar 2025) to 19.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 26.00 Cr..
• For Interest, as of Jun 2025, the value is 88.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 101.00 Cr. (Mar 2025) to 88.00 Cr., marking a decrease of 13.00 Cr..
• For Depreciation, as of Jun 2025, the value is 103.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 109.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 345.00 Cr.. The value appears strong and on an upward trend. It has increased from 320.00 Cr. (Mar 2025) to 345.00 Cr., marking an increase of 25.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 13.00% (Mar 2025) to 29.00%, marking an increase of 16.00%.
• For Net Profit, as of Jun 2025, the value is 244.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 244.00 Cr., marking a decrease of 34.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 19.26. The value appears to be declining and may need further review. It has decreased from 21.96 (Mar 2025) to 19.26, marking a decrease of 2.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:27 am

Growth

Last Updated: September 5, 2025, 2:45 am

Balance Sheet

Last Updated: October 10, 2025, 1:54 pm

Below is a detailed analysis of the balance sheet data for Deepak Fertilisers & Petrochemicals Corp Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 126.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 126.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,110.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,416.00 Cr. (Mar 2024) to 6,110.00 Cr., marking an increase of 694.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,152.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,149.00 Cr. (Mar 2024) to 4,152.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,516.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,226.00 Cr. (Mar 2024) to 2,516.00 Cr., marking an increase of 290.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 12,905.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,917.00 Cr. (Mar 2024) to 12,905.00 Cr., marking an increase of 988.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,292.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,258.00 Cr. (Mar 2024) to 6,292.00 Cr., marking an increase of 34.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,408.00 Cr.. The value appears strong and on an upward trend. It has increased from 754.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 654.00 Cr..
• For Investments, as of Mar 2025, the value is 186.00 Cr.. The value appears to be declining and may need further review. It has decreased from 261.00 Cr. (Mar 2024) to 186.00 Cr., marking a decrease of 75.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,018.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,644.00 Cr. (Mar 2024) to 5,018.00 Cr., marking an increase of 374.00 Cr..
• For Total Assets, as of Mar 2025, the value is 12,905.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,917.00 Cr. (Mar 2024) to 12,905.00 Cr., marking an increase of 988.00 Cr..

Notably, the Reserves (6,110.00 Cr.) exceed the Borrowings (4,152.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Deepak Fertilisers & Petrochemicals Corp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 73.95. This value is within the healthy range. It has increased from 35.05 (Mar 24) to 73.95, marking an increase of 38.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 73.95. This value is within the healthy range. It has increased from 35.05 (Mar 24) to 73.95, marking an increase of 38.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 106.78. This value is within the healthy range. It has increased from 62.66 (Mar 24) to 106.78, marking an increase of 44.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 494.03. It has increased from 431.40 (Mar 24) to 494.03, marking an increase of 62.63.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 494.03. It has increased from 431.40 (Mar 24) to 494.03, marking an increase of 62.63.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 813.88. It has increased from 687.27 (Mar 24) to 813.88, marking an increase of 126.61.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 158.87. This value is within the healthy range. It has increased from 111.65 (Mar 24) to 158.87, marking an increase of 47.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is 126.92. This value is within the healthy range. It has increased from 85.21 (Mar 24) to 126.92, marking an increase of 41.71.
• For PBT / Share (Rs.), as of Mar 25, the value is 94.21. This value is within the healthy range. It has increased from 53.23 (Mar 24) to 94.21, marking an increase of 40.98.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 74.83. This value is within the healthy range. It has increased from 36.22 (Mar 24) to 74.83, marking an increase of 38.61.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 73.95. This value is within the healthy range. It has increased from 35.05 (Mar 24) to 73.95, marking an increase of 38.90.
• For PBDIT Margin (%), as of Mar 25, the value is 19.51. This value is within the healthy range. It has increased from 16.24 (Mar 24) to 19.51, marking an increase of 3.27.
• For PBIT Margin (%), as of Mar 25, the value is 15.59. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 15.59, marking an increase of 3.20.
• For PBT Margin (%), as of Mar 25, the value is 11.57. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 11.57, marking an increase of 3.83.
• For Net Profit Margin (%), as of Mar 25, the value is 9.19. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 9.19, marking an increase of 3.92.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.08. This value is within the healthy range. It has increased from 5.10 (Mar 24) to 9.08, marking an increase of 3.98.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.96. This value is below the healthy minimum of 15. It has increased from 8.18 (Mar 24) to 14.96, marking an increase of 6.78.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 12.25 (Mar 24) to 16.65, marking an increase of 4.40.
• For Return On Assets (%), as of Mar 25, the value is 7.10. This value is within the healthy range. It has increased from 3.74 (Mar 24) to 7.10, marking an increase of 3.36.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.44, marking a decrease of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.63. This value is within the healthy range. It has decreased from 0.74 (Mar 24) to 0.63, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has increased from 0.74 (Mar 24) to 0.82, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.36 (Mar 24) to 1.19, marking a decrease of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.88, marking a decrease of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.09. This value exceeds the healthy maximum of 8. It has increased from 3.98 (Mar 24) to 9.09, marking an increase of 5.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.49. This value is below the healthy minimum of 20. It has decreased from 28.52 (Mar 24) to 11.49, marking a decrease of 17.03.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.02. This value is below the healthy minimum of 20. It has decreased from 16.26 (Mar 24) to 8.02, marking a decrease of 8.24.
• For Earning Retention Ratio (%), as of Mar 25, the value is 88.51. This value exceeds the healthy maximum of 70. It has increased from 71.48 (Mar 24) to 88.51, marking an increase of 17.03.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.98. This value exceeds the healthy maximum of 70. It has increased from 83.74 (Mar 24) to 91.98, marking an increase of 8.24.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.86. This value is within the healthy range. It has increased from 3.49 (Mar 24) to 4.86, marking an increase of 1.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.29. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 3.29, marking an increase of 1.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 17,583.79. It has increased from 10,092.82 (Mar 24) to 17,583.79, marking an increase of 7,490.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has increased from 1.16 (Mar 24) to 1.71, marking an increase of 0.55.
• For EV / EBITDA (X), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 7.16 (Mar 24) to 8.77, marking an increase of 1.61.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.37, marking an increase of 0.64.
• For Retention Ratios (%), as of Mar 25, the value is 88.50. This value exceeds the healthy maximum of 70. It has increased from 71.47 (Mar 24) to 88.50, marking an increase of 17.03.
• For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 2.26, marking an increase of 1.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.37, marking an increase of 0.64.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness